Abstract
Summary
Complete regression of subcutaneously implanted Sarcoma 37 occurred in 62% of host mice treated with a polysaccharide derived from Candida Guilliermondi, in 67% of those treated with Fleischman's zymosan, and in 6% of the controls. No toxic symptoms developed following intraperitoneal injection of either of these polysaccharides, and no hemorrhagic reaction was noted in tumor tissues. Neither substance had any effect on the ascites form of Sarcoma 37 in vivo.
Get full access to this article
View all access options for this article.